Peter Palese, PhD, discusses the future of mRNA vaccines to protect against COVID-19.
CastleVax Inc. Receives BARDA Project NextGen Award Valued at up to $338 Million to Advance Intranasal NDV-based COVID-19 Booster Vaccine into Phase 2b Clinical Efficacy Testing
Mount Sinai to Lead Discussions on Transgender Health, Psychedelic Therapeutics and Long COVID at the 2022 Aspen Ideas: Health and Aspen Ideas Festival
Nasal vaccines may be the next generation of protection against COVID
Biopreparedness Expert Gustavo Palacios, PhD, to Join Mount Sinai, Strengthening Research Collaborations with Department of Defense
Mount Sinai Developing an “End-to-End” Diagnostics Solution for COVID-19 That Incorporates Diagnosis, Treatment Selection, and Monitoring of Disease Course
"The Universal Flu Shot Moves Within Reach"
"100 Year Shadow"
"In Search Of A Universal Flu Vaccine" - Bethany Halford
"Century After Pandemic, Science Takes Its Best Shot At Flu" - Lauran Neergaard